app

Meeting Coverage

CTAD

Clinical Trials on Alzheimer's Disease Conference

Leukemia Drug Shows Promise in Dementia With Lewy Bodies

Cognitive outcomes, biomarkers improved with nilotinib in phase II trial

CTAD over a photo of Madrid Marriott Auditorium Hotel and Conference Center in Madrid, Spain.

Latest CTAD Meeting Coverage

Brain Edema Risk May Be Lower With Modified Donanemab Dosing

Different regimen showed comparable pharmacokinetic and pharmacodynamic results

October 29, 2024

Latest Neurology Meeting Coverage